GFAP and major depressive disorder: Although these results are not typical of an inflammatory response, they are consistent with previous studies that suggest that GFAP expression might decrease in early stages of certain diseases, such as Alzheimer’s disease (AD) [40,41], or in younger patients with disorders such as Major Depressive Disorder (MDD) [42].